The purpose of this study is to facilitate early detection of ME/CFS in people with Long COVID and better understand disease progression.
Despite the myriad of symptoms that patients can have with “Long COVID”, it appears that there are common pathogenic mechanisms for those disparate symptoms. While ME/CFS researchers understand that viral insult combined with other factors likely contribute to the onset of ME/CFS and related conditions like FM, it is important to identify the molecular mechanisms leading to these conditions as well as how to discriminate ME/CFS from other types of long-term sequelae (e.g., neurological conditions, respiratory dysfunction) as early as possible among COVID-19 long-haulers.
Such an approach can lead to the development of algorithms predicting their clinical trajectories. It also offers an opportunity to help COVID-19 long-haulers as well as ME/CFS patients to better understand the progression of the condition and provide insights to identify targeted treatment strategies through precision medicine. Finally, as ME/CFS has historically followed viral outbreaks, the study of COVID-19 long-haulers may shed light on post-infectious fatigue syndrome following infections other than COVID-19.